Ketoconazole Actavis

Ketoconazole, the active ingredient in Ketoconazole Actavis, is an imidazole antifungal presented as a topical formulation for skin use. It treats fungal skin infections such as dermatophyte infections, seborrheic dermatitis and pityriasis versicolor.

GNH USA supplies Ketoconazole Actavis as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketoconazole Actavis is used to treat fungal skin conditions within the dermatologic disease family.

Dermatophyte infections (tinea corporis, tinea cruris, tinea pedis): reduces fungal growth and clears lesions. Seborrheic dermatitis: alleviates scaling, redness and itching. Pityriasis versicolor: eliminates Malassezia overgrowth and restores normal skin colour.

Ketoconazole Actavis may cause local skin reactions.

Common Side Effects: - Burning or stinging at the application site - Itching or mild irritation - Redness or erythema - Dryness or peeling of the skin - Contact dermatitis - Pruritus

Serious or Rare Side Effects: - Severe allergic reactions such as angioedema or anaphylaxis - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe photosensitivity - Systemic absorption leading to hepatic dysfunction (rare) - Bullous skin eruptions - Persistent ulceration or necrosis of the treated area

When using Ketoconazole Actavis, consider the following precautions.

Assess hypersensitivity: confirm no known allergy to ketoconazole or imidazoles. Avoid extensive broken skin: limit use to intact or mildly compromised areas. Do not combine with occlusive dressings: may increase local irritation. Limit duration: follow label‑recommended treatment length to reduce resistance risk. Monitor for hepatic signs if large body surface area is treated. Store at room temperature: keep in original packaging, protect from moisture and light.

Ketoconazole Actavis can interact with other agents; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Concurrent systemic azole antifungals (e.g., oral ketoconazole) – risk of additive toxicity. - Potent CYP3A4 inhibitors applied topically – may increase systemic absorption.

Moderate Interactions (Monitor Closely): - Topical corticosteroids – may mask infection signs. - Alcohol‑based skin products – can enhance irritation. - Sunscreens – may increase photosensitivity when used together. - Other topical antifungals – may cause cumulative irritation.